The Latest Blood Collection Industry Statistics Explained
The global Blood Collection market size was valued at USD 4.13 billion in 2018.
The statistic indicates that the total market size of blood collection products globally reached USD 4.13 billion in 2018. This figure represents the total value of all blood collection products, such as blood collection tubes, needles, and blood bags, that were sold and consumed in the market during that year. The market size provides important insights into the scale and economic significance of the blood collection industry, reflecting the demand for these products worldwide. Understanding the market size can help stakeholders, such as manufacturers, healthcare providers, and policymakers, make informed decisions regarding investment, production, and regulatory measures within the blood collection sector.
The global Blood Collection System market is expected to reach USD 6.58 billion by 2026, at a CAGR of 5.7%.
This statistic indicates that the global Blood Collection System market is projected to grow and reach a value of USD 6.58 billion by 2026, which represents a compound annual growth rate (CAGR) of 5.7% over the forecast period. This growth rate suggests a steady increase in the demand for blood collection systems worldwide, driven by factors such as the rising prevalence of chronic diseases, the increasing number of surgical procedures, and the growing emphasis on blood donation and transfusion services. The expected expansion of the market implies opportunities for existing companies to expand their product offerings and for new entrants to capitalize on the increasing demand for blood collection systems.
North America dominated the market by taking up 44.0% of global revenues in 2018.
This statistic indicates that North America held a significant share of the global market in 2018, accounting for 44.0% of total revenues generated worldwide. This dominance suggests that North America’s market presence was particularly strong compared to other regions during that year. Factors contributing to this dominance could include the region’s economic strength, consumer demand, technological advancements, or market competitiveness. As a result, businesses operating in North America may have experienced relatively higher revenues and market opportunities compared to their counterparts in other regions.
Blood collection utilizing needles and syringes held over 43.0% revenue share in 2018.
In 2018, the revenue generated from blood collection procedures that utilized needles and syringes accounted for over 43.0% of the total revenue in the industry. This statistic indicates that a significant portion of the revenue generated within the blood collection sector was attributed to procedures that involved the use of needles and syringes. The high revenue share of this particular method suggests that it is a commonly used and potentially high-profit method within the industry. Understanding the revenue distribution among different blood collection methods is essential for stakeholders to make informed decisions and investments within the field.
Hospitals carried out approximately 79% of all blood collections in 2019.
The statistic “Hospitals carried out approximately 79% of all blood collections in 2019” indicates that the majority of blood collections in 2019 were performed by hospitals, accounting for approximately 79% of the total. This suggests that hospitals play a significant role in the process of blood collection, likely due to their access to trained medical staff and equipment necessary for such procedures. The statistic implies that hospitals are key players in the healthcare system’s blood collection efforts, highlighting their importance in ensuring an adequate and efficient supply of blood for medical treatments and emergencies.
Demand of blood components in the healthcare industry is expected to grow at 3% annually.
The statistic that the demand for blood components in the healthcare industry is expected to grow at a rate of 3% annually indicates a projected increase in the need for blood products over time. This growth rate suggests that healthcare facilities will require more blood components, such as red blood cells, platelets, and plasma, to meet the demands of patient care. Factors contributing to this expected growth may include population aging, advancements in medical treatments that require blood transfusions, and an increase in complex surgical procedures. Understanding this trend is crucial for healthcare providers to anticipate and plan for the increased demand for blood components to ensure adequate supply and proper patient care.
Nearly 50% of blood collections were used for transfusions in acute care settings in 2018.
The statistic “Nearly 50% of blood collections were used for transfusions in acute care settings in 2018” indicates that approximately half of the total blood collected during the year 2018 was utilized for transfusions specifically in acute care settings such as hospitals, emergency rooms, and other medical facilities providing immediate medical attention. This statistic highlights the significant role that blood transfusions play in the treatment and management of patients with acute medical conditions, such as trauma, surgeries, and severe illnesses. It underscores the critical need for a steady and adequate blood supply to meet the demands of acute care settings and ensure timely and effective patient care in these high-intensity healthcare environments.
96.9% of blood centers encourage voluntary unpaid donation, representing 79 countries.
The statistic states that 96.9% of blood centers across 79 countries actively promote voluntary unpaid blood donation. This indicates a widespread global consensus and effort towards ensuring the safety and sustainability of blood supplies by encouraging altruistic donations. The high percentage suggests a strong commitment to ethical practices within the blood donation community, emphasizing the importance of voluntary contributions over paid donations. By emphasizing voluntary unpaid donation, blood centers aim to ensure that donors give out of genuine altruism and care for others’ well-being rather than financial gain, ultimately leading to safer and more reliable blood supplies for those in need.
More than 2 million units of blood components are transfused every year in the UK.
The statistic ‘More than 2 million units of blood components are transfused every year in the UK’ highlights the significant demand for blood transfusions in the United Kingdom. This statistic indicates the crucial role that blood transfusions play in the healthcare system, serving as a lifeline for patients in need of blood due to surgeries, accidents, or medical conditions. The scale of over 2 million units being transfused annually underscores the importance of regular blood donations to meet this demand and emphasizes the ongoing necessity for maintaining an adequate blood supply to ensure the well-being and treatment of patients across the country.
Nearly 21 million blood components are transfused each year in the U.S.
The statistic that nearly 21 million blood components are transfused each year in the U.S. highlights the significant demand and impact of blood transfusions in the healthcare system. Blood components are vital for saving lives and treating various medical conditions, such as surgeries, cancer treatments, trauma cases, and chronic illnesses. This statistic underscores the importance of maintaining an adequate blood supply through regular blood donations to ensure that patients in need have access to lifesaving transfusions. It also emphasizes the critical role of blood banks, healthcare providers, and organizations in coordinating and facilitating the transfusion process to support patient care across the country.
By 2025, liquid biopsy is projected to hold over 35% revenue share in blood collection market.
The statistic “By 2025, liquid biopsy is projected to hold over 35% revenue share in the blood collection market” suggests that by the year 2025, liquid biopsy technologies are expected to account for more than one-third of the total revenue generated in the blood collection market. Liquid biopsy refers to a non-invasive method of collecting and analyzing biomarkers in the blood, such as circulating tumor cells or cell-free DNA, for diagnostic and monitoring purposes. This projection indicates a growing trend towards the adoption of liquid biopsy techniques in the healthcare industry, potentially replacing or complementing traditional methods of blood collection for various applications, especially in the field of oncology.
117.4 million blood donations are collected globally every year.
The statistic that 117.4 million blood donations are collected globally every year represents the magnitude of the ongoing effort to meet the critical demand for blood transfusions and medical treatments worldwide. This statistic highlights the incredible generosity and altruism of individuals who donate blood to save lives and improve health outcomes for patients in need. The widespread collection of blood donations on such a large scale is crucial for addressing medical emergencies, supporting patients undergoing surgeries, managing chronic conditions, and advancing healthcare systems around the world. This statistic underscores the importance of promoting regular blood donations to ensure an adequate and sustainable supply of blood for medical purposes and emergency situations.
The Asia Pacific market for blood collection is expected to see a growth rate of 6.9% between 2017 and 2025.
The statistic indicates that the Asia Pacific market for blood collection is projected to increase at an annual growth rate of 6.9% from 2017 to 2025. This growth rate suggests that there is a growing demand for blood collection products and services in the region, which could be driven by factors such as increasing healthcare infrastructure, rising healthcare expenditure, and a growing aging population. The steady growth rate signifies a positive trend in the market and presents opportunities for companies operating in the blood collection sector to expand their presence and offerings in the Asia Pacific region over the specified time frame.
The global blood collection devices market is expected to register a CAGR of 5.5% till 2025.
This statistic suggests that the global blood collection devices market is projected to experience a Compound Annual Growth Rate (CAGR) of 5.5% over the period until 2025. This indicates that the market for blood collection devices is expected to expand steadily at a rate of 5.5% annually, reflecting the anticipated growth and demand for these products. The increasing prevalence of diseases, advancements in healthcare infrastructure, rising number of surgical procedures, and the growing awareness about blood donation and transfusion are some of the factors likely to drive this market growth. This forecast provides valuable insight for stakeholders in the healthcare industry to make informed decisions and strategic plans to capitalize on the expected market growth in the blood collection devices sector.
Vacuum blood collection devices led the market in 2018 with a valuation of USD 1.5 billion.
The statistic stating that vacuum blood collection devices led the market in 2018 with a valuation of USD 1.5 billion indicates that vacuum blood collection devices, which are widely used in medical labs and healthcare settings for drawing blood samples, were the most significant segment within the blood collection equipment market in terms of revenue in 2018. This valuation suggests that there was a high demand for vacuum blood collection devices during that year, likely due to factors such as efficiency, accuracy, and hygiene in blood sample collection processes. The substantial market share and revenue attributed to these devices in 2018 highlight their importance and dominance in the industry during that period.
The South American blood collection market is expected to grow at a CAGR of 4.9% between 2020 and 2025.
This statistic indicates that the South American blood collection market is forecasted to experience a Compound Annual Growth Rate (CAGR) of 4.9% over the period from 2020 to 2025. This suggests a steady and positive growth trend in the market for collecting blood products in South America, with expectations for continued expansion in the coming years. Factors such as advancements in healthcare infrastructure, increasing demand for blood components, and rising awareness about the importance of blood donation may contribute to this projected growth rate. Overall, this statistic provides insight into the potential opportunities and development of the blood collection market in South America over the specified time frame.
In 2025, Blood bags will account for $687.5 million in the market.
The statistic ‘In 2025, blood bags will account for $687.5 million in the market’ reflects the projected total value of blood bags sales within the specified year. This figure indicates the estimated financial impact of blood bags on the market, suggesting a significant demand for these products based on various factors such as increasing healthcare needs, advancements in medical treatments, and rising awareness of blood transfusion safety. The substantial market value of blood bags underscores their critical role in healthcare settings, particularly in blood collection, storage, and transfusion processes, highlighting the importance and economic significance of this medical supply in meeting the needs of patients and healthcare facilities.
Mechanical blood collection devices account for over 75% of the global market revenue.
The statistic indicates that mechanical blood collection devices, which are designed to draw blood for various medical purposes, hold a significant share of the global market revenue, constituting more than 75% of the total market value. This suggests that mechanical devices such as needles, syringes, and lancets are widely used in blood collection procedures worldwide compared to other types of devices. The high market share of these mechanical devices could be attributed to factors such as their cost-effectiveness, ease of use, and established safety standards. This statistic highlights the dominance and preference for mechanical blood collection devices in the healthcare industry and underscores their importance in facilitating essential medical procedures efficiently and effectively.
Automated Blood Collection Equipment is predicted to grow at a CAGR rate of 5.8% from 2019-2026.
The statistic indicates that the Automated Blood Collection Equipment market is projected to experience a Compound Annual Growth Rate (CAGR) of 5.8% between the years 2019 and 2026. This suggests a steady increase in the demand for automated blood collection equipment over the specified period, with a consistent annual growth rate of 5.8%. This growth rate may be driven by factors such as technological advancements, increasing prevalence of blood-related disorders, rising investments in healthcare infrastructure, and a growing awareness regarding the benefits of automated blood collection equipment. Overall, this statistic signifies a positive trend for the Automated Blood Collection Equipment market, indicating potential opportunities for manufacturers, healthcare providers, and consumers in the industry.
References
0. – https://www.www.nhsbt.nhs.uk
1. – https://www.www.reportsanddata.com
2. – https://www.www.who.int
3. – https://www.www.unionjournalism.com
4. – https://www.www.gminsights.com
5. – https://www.www.marketdataforecast.com
6. – https://www.www.meticulousresearch.com
7. – https://www.www.grandviewresearch.com
8. – https://www.www.redcrossblood.org
9. – https://www.www.fortunebusinessinsights.com
